Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A10997 | 31086120 | Int J Mol Sci | Hepatoprotective Effect of Kombucha Tea in Rodent Model of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis. | 2019 | Details |
| A10998 | 31085647 | Proc Natl Acad Sci U S A | sGC stimulator praliciguat suppresses stellate cell fibrotic transformation and inhibits fibrosis and inflammation in models of NASH. | 2019 | Details |
| A10999 | 31085617 | Postgrad Med J | Diagnosis and management of non-alcoholic fatty liver disease. | 2019 | Details |
| A11000 | 31085402 | Biosens Bioelectron | Porous graphene-black phosphorus nanocomposite modified electrode for detection of leptin. | 2019 | Details |
| A11001 | 31085337 | Clin Gastroenterol Hepatol | Alcoholic and Nonalcoholic Fatty Liver Disease and Incident Hospitalization for Liver and Cardiovascular Diseases. | 2019 | Details |
| A11004 | 31083855 | Invest Educ Enferm | Effect of tele-nursing in the improving of the ultrasound findings in patients with nonalcoholic fatty liver diseases: A Randomized Clinical Trial study. | 2018 | Details |
| A11006 | 31083505 | Cells | Protective Effects of Licochalcone A Ameliorates Obesity and Non-Alcoholic Fatty Liver Disease Via Promotion of the Sirt-1/AMPK Pathway in Mice Fed a High-Fat Diet. | 2019 | Details |
| A11007 | 31083413 | Int J Mol Sci | Arazyme Suppresses Hepatic Steatosis and Steatohepatitis in Diet-Induced Non-Alcoholic Fatty Liver Disease-Like Mouse Model. | 2019 | Details |
| A11008 | 31082856 | Clin Transl Gastroenterol | Role of Fatty Liver Index and Metabolic Factors in the Prediction of Nonalcoholic Fatty Liver Disease in a Lean Population Receiving Health Checkup. | 2019 | Details |
| A11009 | 31082855 | Clin Transl Gastroenterol | Serum Soluble Receptor for AGE (sRAGE) Levels Are Associated With Unhealthy Lifestyle and Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A11010 | 31082799 | J Endocrinol | Impact of exenatide on mitochondrial lipid metabolism in mice with nonalcoholic steatohepatitis. | 2019 | Details |
| A11012 | 31082341 | Zhonghua Gan Zang Bing Za Zhi | [Application of heme oxygenase 1 in the diagnosis of non-alcoholic fatty liver disease]. | 2019 | Details |
| A11013 | 31081997 | Liver Int | Trends in hospitalizations for chronic liver disease-related liver failure in the United States, 2005-2014. | 2019 | Details |
| A11014 | 31081822 | J Vis Exp | An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes. | 2019 | Details |
| A11016 | 31081390 | Expert Rev Gastroenterol Hepatol | Nonalcoholic fatty liver disease and steatohepatitis in people living with HIV. | 2019 | Details |
| A11017 | 31081165 | Hepatology | Hepatocyte Deletion of Triglyceride-Synthesis Enzyme Acyl CoA: Diacylglycerol Acyltransferase 2 Reduces Steatosis Without Increasing Inflammation or Fibrosis in Mice. | 2019 | Details |
| A11018 | 31080822 | Biomed Res Int | Diabetes Mellitus and Risk of Hepatic Fibrosis/Cirrhosis. | 2019 | Details |
| A11019 | 31080703 | Curr Epidemiol Rep | Environmental risk factors for liver cancer and nonalcoholic fatty liver disease. | 2019 | Details |
| A11021 | 31080056 | Ann Hepatol | Non-alcoholic fatty liver disease and neurological defects. | 2019 | Details |
| A11022 | 31079449 | J Med Chem | Design, Synthesis, and Preclinical Efficacy of Novel Nonretinoid Antagonists of Retinol-Binding Protein 4 in the Mouse Model of Hepatic Steatosis. | 2019 | Details |
| A11023 | 31078721 | Diabetes Metab | Circulating retinol-binding protein 4 is associated with the development and regression of non-alcoholic fatty liver disease. | 2019 | Details |
| A11024 | 31078624 | Gastroenterology | Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic Steatohepatitis. | 2019 | Details |
| A11025 | 31078545 | Life Sci | Histological evaluation of nintedanib in non-alcoholic steatohepatitis mice. | 2019 | Details |
| A11027 | 31077838 | Clin Gastroenterol Hepatol | Daily Aspirin Use Associated With Reduced Risk For Fibrosis Progression In Patients With Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A11028 | 31077811 | Pharmacol Res | Drug-induced liver steatosis in patients with HIV infection. | 2019 | Details |
| A11029 | 31077075 | J Nucl Cardiol | Non-alcoholic fatty liver disease with reduced myocardial FDG uptake is associated with coronary atherosclerosis. | 2019 | Details |
| A11030 | 31077025 | Obes Surg | Measurement of Liver Stiffness with 2D-Shear Wave Elastography (2D-SWE) in Bariatric Surgery Candidates Reveals Acceptable Diagnostic Yield Compared to Liver Biopsy. | 2019 | Details |
| A11031 | 31076985 | Dig Dis Sci | Vitamin E Ameliorates Lipid Metabolism in Mice with Nonalcoholic Fatty Liver Disease via Nrf2/CES1 Signaling Pathway. | 2019 | Details |
| A11032 | 31076404 | Gut | Myeloid cells in liver and bone marrow acquire a functionally distinct inflammatory phenotype during obesity-related steatohepatitis. | 2019 | Details |
| A11033 | 31076231 | Ultrasound Med Biol | Characterizing Fatty Liver in vivo in Rabbits, Using Quantitative Ultrasound. | 2019 | Details |
| A11034 | 31075323 | J Hepatol | The beneficial effects of Mediterranean diet over low-fat diet may be mediated by decreasing hepatic fat content. | 2019 | Details |
| A11035 | 31075230 | Anal Biochem | Role of identified RNA N6-methyladenosine methylation in liver. | 2019 | Details |
| A11036 | 31075051 | J Am Coll Nutr | Circulating ALT Levels in Healthy Volunteers Over Life-Span: Assessing Aging Paradox and Nutritional Implications. | 2019 | Details |
| A11037 | 31074909 | J Bone Miner Res | Nonalcoholic Fatty Liver Disease in The Rotterdam Study: About Muscle Mass, Sarcopenia, Fat Mass, and Fat Distribution. | 2019 | Details |
| A11040 | 31071683 | Endocr Connect | Steroid metabolomic signature of liver disease in nonsyndromic childhood obesity. | 2019 | Details |
| A11041 | 31071511 | Biomed Pharmacother | Therapeutic effects of curcumin and ursodexycholic acid on non-alcoholic fatty liver disease. | 2019 | Details |
| A11042 | 31071367 | J Hepatol | Outcomes of liver transplantation for non-alcoholic steatohepatitis: A European Liver Transplant Registry study. | 2019 | Details |
| A11043 | 31071311 | Metabolism | Fatty liver in lipodystrophy: A review with a focus on therapeutic perspectives of adiponectin and/or leptin replacement. | 2019 | Details |
| A11044 | 31070764 | J Nutr | Triplet Male Lambs Are More Susceptible than Twins to Dietary Soybean Oil-Induced Fatty Liver. | 2019 | Details |
| A11046 | 31070259 | Hepatology | Unexpected Rapid Increase in the Burden of NAFLD in China From 2008 to 2018: A Systematic Review and Meta-Analysis. | 2019 | Details |
| A11047 | 31069793 | J Cell Physiol | S100A16, a novel lipogenesis promoting factor in livers of mice and hepatocytes in vitro. | 2019 | Details |
| A11048 | 31069057 | F1000Res | Recent advances in the understanding and management of polycystic ovary syndrome. | 2019 | Details |
| A11049 | 31068503 | Endocr J | High sex hormone-binding globulin concentration is a risk factor for high fibrosis-4 index in middle-aged Japanese men. | 2019 | Details |
| A11050 | 31067824 | J Clin Med | Lysosomal Acid Lipase as a Molecular Target of the Very Low Carbohydrate Ketogenic Diet in Morbidly Obese Patients: The Potential Effects on Liver Steatosis and Cardiovascular Risk Factors. | 2019 | Details |
| A11051 | 31067493 | Diabetes Metab | Association between non-alcoholic fatty liver disease and decreased lung function in adults: A systematic review and meta-analysis. | 2019 | Details |
| A11052 | 31065991 | Adv Ther | A Structured Literature Review of the Epidemiology and Disease Burden of Non-Alcoholic Steatohepatitis (NASH). | 2019 | Details |
| A11053 | 31064820 | Biosci Rep | LncRNA-H19 promotes hepatic lipogenesis by directly regulating miR-130a/PPARγ axis in non-alcoholic fatty liver disease. | 2019 | Details |
| A11054 | 31064654 | Biochem Biophys Res Commun | IDH2 protects against nonalcoholic steatohepatitis by alleviating dyslipidemia regulated by oxidative stress. | 2019 | Details |
| A11055 | 31064105 | J Clin Med | Cardiovascular Health Metrics in the Development and Regression of Nonalcoholic Fatty Liver Disease: A Cohort Study. | 2019 | Details |
| A11056 | 31064103 | Nutrients | Fermented Cordyceps militaris Extract Prevents Hepatosteatosis and Adipocyte Hypertrophy in High Fat Diet-Fed Mice. | 2019 | Details |
| A11057 | 31064058 | Int J Mol Sci | Cardio-Metabolic Disorders in Non-Alcoholic Fatty Liver Disease. | 2019 | Details |
| A11058 | 31063974 | Endocr Connect | Elevated serum neuregulin 4 levels in patients with hyperthyroidism. | 2019 | Details |
| A11059 | 31063640 | Hepatology | Pharmacologic Inhibition of Epidermal Growth Factor Receptor Suppresses Nonalcoholic Fatty Liver Disease in a Murine Fast-Food Diet Model. | 2019 | Details |
| A11060 | 31062641 | Adipocyte | PNPLA3-I148M: a problem of plenty in non-alcoholic fatty liver disease. | 2019 | Details |
| A11061 | 31062612 | Artif Cells Nanomed Biotechnol | Long non-coding RNA NEAT1 promotes steatosis via enhancement of estrogen receptor alpha-mediated AQP7 expression in HepG2 cells. | 2019 | Details |
| A11062 | 31061949 | Hepatol Commun | Looking Into the Crystal Ball: Predicting the Future Challenges of Fibrotic NASH Treatment. | 2019 | Details |
| A11063 | 31061888 | JGH Open | High prevalence of non-alcoholic fatty liver disease among healthy male blood donors of urban India. | 2019 | Details |
| A11064 | 31061886 | JGH Open | Association between non-alcoholic fatty liver disease evaluated by transient elastography with extracranial carotid atherosclerosis in a multiethnic Asian community. | 2018 | Details |
| A11066 | 31061050 | BMJ Open | Cohort profile: the Trivandrum non-alcoholic fatty liver disease (NAFLD) cohort. | 2019 | Details |
| A11068 | 31060787 | J Clin Densitom | Moderation Effect of Handgrip Strength on the Associations of Obesity and Metabolic Syndrome With Fatty Liver in Adolescents. | 2019 | Details |
| A11069 | 31060668 | Zhongguo Yi Xue Ke Xue Yuan Xue Bao | [Associations of Non-alcoholic Fatty Liver Disease with Prevalence,Severity,and Prognosis of Coronary Heart Disease]. | 2019 | Details |
| A11070 | 31060228 | Biomolecules | Inhibiting Extracellular Cathepsin D Reduces Hepatic Steatosis in Sprague⁻Dawley Rats †. | 2019 | Details |
| A11071 | 31058888 | J Vis Exp | Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis (NASH) Resolution. | 2019 | Details |
| A11072 | 31057993 | Cureus | Metabolic Syndrome in Patients with Non-alcoholic Fatty Liver Disease: A Community Based Cross-sectional study. | 2019 | Details |
| A11074 | 31057294 | World J Gastroenterol | Repurposing drugs to target nonalcoholic steatohepatitis. | 2019 | Details |
| A11075 | 31055550 | Wiad Lek | Comorbidity severity index as a new tool for assessment of co-existing diseases in patients with non-alcoholic fatty liver disease at the carbohydrate metabolism disorder background and concomitant subclinical hypothyroidism. | 2019 | Details |
| A11076 | 31055525 | Wiad Lek | The role of endothelial dysfunction in the progression mechanisms of non-alcoholic steatohepatitis in patients with obesity and chronic kidney disease. | 2019 | Details |
| A11077 | 31055233 | J Nutr Biochem | Fish oil alleviates circadian bile composition dysregulation in male mice with NAFLD. | 2019 | Details |
| A11078 | 31055201 | Environ Int | Low-dose PCB126 compromises circadian rhythms associated with disordered glucose and lipid metabolism in mice. | 2019 | Details |
| A11079 | 31054980 | Ann Hepatol | Validation of PNPLA3 polymorphisms as risk factor for NAFLD and liver fibrosis in an admixed population. | 2019 | Details |
| A11080 | 31054977 | Ann Hepatol | Interaction of TM6SF2 E167K and PNPLA3 I148M variants in NAFLD in northeast China. | 2019 | Details |
| A11081 | 31054837 | Prim Care Diabetes | Association of non-alcoholic fatty liver disease with microvascular complications of type 2 diabetes. | 2019 | Details |
| A11082 | 31053512 | Clin Nutr | Low muscle mass and low muscle strength associate with nonalcoholic fatty liver disease. | 2019 | Details |
| A11083 | 31051410 | Atherosclerosis | The novel adipokine CTRP1 is significantly associated with the incidence of major adverse cardiovascular events. | 2019 | Details |
| A11084 | 31051106 | Cell | Deficient Endoplasmic Reticulum-Mitochondrial Phosphatidylserine Transfer Causes Liver Disease. | 2019 | Details |
| A11085 | 31050979 | Wiad Lek | Association of nonalcoholic fatty liver disease with small intestine bacterial overgrowth in obese children. | 2019 | Details |
| A11086 | 31049168 | Middle East J Dig Dis | Role of MicroRNAs in Pathophysiology of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis. | 2018 | Details |
| A11087 | 31048208 | J Nutr Biochem | Metabolic dysfunction following weight regain compared to initial weight gain in a high-fat diet-induced obese mouse model. | 2019 | Details |
| A11088 | 31047909 | Metabolism | Association between Helicobacter pylori infection and risk of nonalcoholic fatty liver disease: An updated meta-analysis. | 2019 | Details |
| A11089 | 31046975 | Gastroenterol Clin North Am | Liver Fibrosis Determination. | 2019 | Details |
| A11090 | 31046673 | Mol Med | Increased proteinase 3 and neutrophil elastase plasma concentrations are associated with non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes. | 2019 | Details |
| A11091 | 31046138 | Clin Endocrinol (Oxf) | The haemoglobin glycation index is associated with nonalcoholic fatty liver disease in healthy subjects. | 2019 | Details |
| A11092 | 31045941 | AIDS | A gathering storm: HIV infection and nonalcoholic fatty liver disease in low and middle-income countries. | 2019 | Details |
| A11093 | 31045779 | Medicine (Baltimore) | Presence of diabetic retinopathy is lower in type 2 diabetic patients with non-alcoholic fatty liver disease. | 2019 | Details |
| A11094 | 31045630 | Eur J Gastroenterol Hepatol | Comparison of anthropometric measurements for prediction of the atherosclerosis and liver histology in young adults with nonalcoholic fatty liver disease. | 2019 | Details |
| A11095 | 31044438 | Hepatology | NOD-like receptor C4 Inflammasome Regulates the Growth of Colon Cancer Liver Metastasis in NAFLD. | 2019 | Details |
| A11096 | 31044315 | Curr Diab Rep | Epigenetic Markers and Microbiota/Metabolite-Induced Epigenetic Modifications in the Pathogenesis of Obesity, Metabolic Syndrome, Type 2 Diabetes, and Non-alcoholic Fatty Liver Disease. | 2019 | Details |
| A11097 | 31043436 | J Pharmacol Exp Ther | Characterization of Vitamin A Metabolome in Human Livers With and Without Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A11098 | 31043271 | Biochem Biophys Res Commun | Hepatocellular iNOS protects liver from NASH through Nrf2-dependent activation of HO-1. | 2019 | Details |
| A11099 | 31042237 | Rev Gastroenterol Peru | [Predictors of infection and mortality in patients with liver cirrhosis in the high complexity hospital Virgen de la Puerta from Trujillo, Peru]. | 2020 | Details |
| A11100 | 31041790 | Semin Liver Dis | Lipid Droplet Formation and Lipophagy in Fatty Liver Disease. | 2019 | Details |
| A11101 | 31041786 | Semin Liver Dis | Macrophages as Key Players during Adipose Tissue-Liver Crosstalk in Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A11102 | 31041226 | J Family Med Prim Care | Biochemical markers and lipid profile in nonalcoholic fatty liver disease patients in the PERSIAN Guilan cohort study (PGCS), Iran. | 2019 | Details |
| A11103 | 31040626 | Ann Gastroenterol | Prevalence of non-alcoholic fatty liver disease on computed tomography in patients with inflammatory bowel disease visiting an emergency department. | 2019 | Details |
| A11105 | 31040374 | Sci Rep | Metformin attenuates the onset of non-alcoholic fatty liver disease and affects intestinal microbiota and barrier in small intestine. | 2019 | Details |
| A11106 | 31040024 | Atherosclerosis | No association between aortic stiffness and liver steatosis in morbidly obese patients. | 2019 | Details |
| A11107 | 31039348 | Exp Cell Res | Epoxyeicosatrienoic intervention improves NAFLD in leptin receptor deficient mice by an increase in PGC1α-HO-1-PGC1α-mitochondrial signaling. | 2019 | Details |
| A11108 | 31039007 | Am J Physiol Endocrinol Metab | Sex modulates hepatic mitochondrial adaptations to high-fat diet and physical activity. | 2019 | Details |
| A11109 | 31038030 | Int J Vitam Nutr Res | Tissue Changes in the Development of Fatty Liver by Chronic Ingestion of Sucrose Associated with Obesity and Dyslipidemia in Rats. | 2019 | Details |
| A11110 | 31037218 | J Nutr Sci | Coffee prevents fatty liver disease induced by a high-fat diet by modulating pathways of the gut-liver axis. | 2019 | Details |